Tctc Holdings, LLC Vertex Pharmaceuticals Inc Transaction History

Tctc Holdings, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$177.01 - $223.45 $22,126 - $27,931	-125 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$181.39 - $202.99 $22,673 - $25,373	125 New	125 $23,000
Q2 2021 Aug 11, 2021	SELL	$187.49 - $221.1 $9,374 - $11,055	-50 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $12,782 - $15,155	50 New	50 $14,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Tctc Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Tctc Holdings, LLC with notifications on news.